🇺🇸 Viatris IncVTRS

M&A Form 8-K 17-11-2026 09:44:56 EST

Subject: 8-K Items 2.01, 7.01, 9.01

Overview: Completed the acquisition of Pacira BioSciences for $36.50 per share in cash, with Pacira expected to contribute $90 million to $100 million in revenue.

Source: SEC EDGAR · Original filing

Open document in a new tab

Get filings like this in Telegram the moment they are published — for the companies you follow.

Start 30-day trial About Finterest